Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* CKD stage 1 patients~* Older than 18 years of age~* Type 2 Diabetic patients~* Proteinuria~* Hypertension~Exclusion Criteria:~* History of coronary artery disease~* Smokers~* Taking statins or renin-angiotensin blockers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Amlodipine (Type: EXPERIMENTAL): None
- Valsartan (Type: EXPERIMENTAL): None
- Valsartan+Amlodipine (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).